Amino acid concentrations in serum after intake of plant based protein sources

Completed

• Conditions: Biobeschikbaarheid; niet van toepassing

• Registration Number: NL-OMON56237
• Lead Sponsor: utricia Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 32

Inclusion Criteria

1. Age >= 18 and <= 70 years
2. Body Mass Index (BMI) >= 18.5 and <= 27.0 kg/m2
3. Written informed consent
4. Willingness and ability to comply with the protocol
5. Judged by the Investigator to be in good health

Exclusion Criteria

1. Any gastrointestinal (GI) disease or surgery that may interfere with GI
function and/or protein metabolism, including but not limited to
phenylketonuria, pancreatitis, short bowel syndrome, celiac disease, Crohn*s
disease, in the opinion of the Investigator
2. Known renal or hepatic diseases that may interfere with protein metabolism,
including but not limited to acute hepatitis, chronic liver disease, nephritis,
cystinuria, chronic kidney disease, in the opinion of the Investigator
3. Use of systemic medication within the past 3 weeks prior to screening which
in the opinion of the Investigator may influence gastric acid production and/or
gastrointestinal motility or function and/or protein metabolism (for example:
antibiotics, anticonvulsants, prokinetics, antacids, opioid analgesics,
anticoagulants, corticosteroids, laxatives, growth hormone, testosterone,
immunosuppressants, or insulin).
4. Allergy to soy, pea and/or cow*s milk protein
5. Adherence to a weight loss program
6. Current eating disorder, e.g. anorexia nervosa or bulimia
7. Known pregnancy and/or lactation
8. Current smoking or stopped smoking for < 1 month prior to screening (except
for incidental smoking of <= 3 cigarettes/cigars/pipes per week on average in
the last month prior to screening)
9. Average alcohol use of > 21 glasses per week for men or > 14 glasses per
week for women (on average during the last 6 months prior to screening)
10. Drug or medicine abuse in opinion of the investigator
11. Any known bleeding disorder
12. Known difficulties with placement of and/or blood drawings from a cannula
13. Active participation in any other study with investigational or marketed
products concomitantly or within 4 weeks prior to screening
14. Major medical or major surgical event requiring hospitalization within the
preceding 3 months and/or scheduled in the period of study participation
15. Investigator*s uncertainty about the willingness or ability of the subject
to comply with the protocol requirements
16. Employees of Nutricia Research and/or their family members or relatives

Study & Design

• Study Type: Interventional
• Study Design: Not specified